Zantac is a drug used by hundreds of millions of people around the world every day. The recent discovery of NDMA in Zantac means that all of these people have been ingesting the toxic carcinogen on a daily basis for years. Even more worrying is the fact that the drug companies that make and sell Zantac knew or should have known that drug users had dangerous levels of NDMA. Now, the makers of Sanofi and generics Zantac face huge liability from hundreds of thousands of potential plaintiffs.
What about the plaintiffs in the Zantac lawsuit?
N-nitrosodimethylamine ("NDMA") is a chemical byproduct of several industrial processes. NDMA has long been recognized as a potential human carcinogen. NDMA is extremely noxious to the human body, especially the liver, and is strongly associated with various types of cancer.
Zantac attorney-at-law made multiple allegations of harassment. But the crux of the allegations is that the plaintiff's claim can at best be distilled into a claim that the Zantac/ranitidine design is inherently flawed because of the risk of NDMA formation. Therefore, there should be a warning to warn doctors and patients of this risk.
Image Source: Google
Who can file a lawsuit on Zantac?
The law firm is investigating potential applicants at Zantac who have been using Zantac regularly for a long period of time and who have subsequently been diagnosed with cancer, specifically one of the following types of cancer:
- Stomach cancer
- Bladder cancer
- Breast cancer (new study set to confirm this)
- Heart cancer
- Kidney cancer
- Testicular cancer
- Cervical cancer
- Small bowel cancer
- Colon cancer
- Esophageal cancer